Kevin O Lillehei, Sarah Travers, Garni Barkhoudarian, Nelson M Oyesiku, Isabelle M Germano, D Ryan Ormond
{"title":"神经外科医师大会对功能性垂体腺瘤患者手术作用的系统评价和循证指南。","authors":"Kevin O Lillehei, Sarah Travers, Garni Barkhoudarian, Nelson M Oyesiku, Isabelle M Germano, D Ryan Ormond","doi":"10.1227/neu.0000000000003559","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>With the recent improvements in surgery, along with our ability to manage many pituitary tumors medically, the exact role of surgery for the treatment of functioning pituitary adenomas (PA) remains unclear. The purpose of this evidence-based clinical practice guideline was to determine the role of surgery in the treatment of functioning PA.</p><p><strong>Methods: </strong>A systematic review of the literature was performed using the National Library of Medicine/PubMed database and Embase for studies relevant to the role of surgery in the treatment of patients with functioning PA. Clinical studies evaluating the role of trans-sphenoidal surgery vs medical management, endoscopic techniques vs microsurgery, the benefit of the use of adjunct surgical techniques to patient outcome, and the role of second surgery were selected for review.</p><p><strong>Results: </strong>The literature search yielded 7073 abstracts. Of these, 60 studies met inclusion criteria, and evidence-based guidelines were formulated on the use of surgical resection compared with medical management, the use of endoscopic techniques and/or other surgical adjunct techniques, and the benefit of reoperation for recurrent tumors compared with medical treatment and/or radiation.</p><p><strong>Conclusion: </strong>Class III evidence suggests a benefit to surgery over medical management for growth hormone-secreting adenomas without evidence to support a benefit to pretreatment with a somatostatin analog before surgery. Class III evidence suggests a benefit to medical management over surgery in the treatment of patients with prolactinomas at primary diagnosis. There are insufficient data to support the benefit of endoscopic surgery compared with microscopic surgery, with or without additional adjuvant surgical techniques, for extent of surgical resection, hormone remission, length of stay, or complication rate, in the treatment of functional PA. There is a suggestion, however, that the endoscopic technique may be superior to the microscopic technique, for a shorter operative time and for extent of surgical resection and hormone remission rates for noninvasive pituitary macroadenomas. Similarly, there are insufficient data to support the use of reoperation for recurrent tumor compared with radiation and/or medical treatment.</p>","PeriodicalId":19276,"journal":{"name":"Neurosurgery","volume":"97 3S","pages":"S24-S35"},"PeriodicalIF":3.9000,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for the Role of Surgery for Patients With Functioning Pituitary Adenomas.\",\"authors\":\"Kevin O Lillehei, Sarah Travers, Garni Barkhoudarian, Nelson M Oyesiku, Isabelle M Germano, D Ryan Ormond\",\"doi\":\"10.1227/neu.0000000000003559\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>With the recent improvements in surgery, along with our ability to manage many pituitary tumors medically, the exact role of surgery for the treatment of functioning pituitary adenomas (PA) remains unclear. The purpose of this evidence-based clinical practice guideline was to determine the role of surgery in the treatment of functioning PA.</p><p><strong>Methods: </strong>A systematic review of the literature was performed using the National Library of Medicine/PubMed database and Embase for studies relevant to the role of surgery in the treatment of patients with functioning PA. Clinical studies evaluating the role of trans-sphenoidal surgery vs medical management, endoscopic techniques vs microsurgery, the benefit of the use of adjunct surgical techniques to patient outcome, and the role of second surgery were selected for review.</p><p><strong>Results: </strong>The literature search yielded 7073 abstracts. Of these, 60 studies met inclusion criteria, and evidence-based guidelines were formulated on the use of surgical resection compared with medical management, the use of endoscopic techniques and/or other surgical adjunct techniques, and the benefit of reoperation for recurrent tumors compared with medical treatment and/or radiation.</p><p><strong>Conclusion: </strong>Class III evidence suggests a benefit to surgery over medical management for growth hormone-secreting adenomas without evidence to support a benefit to pretreatment with a somatostatin analog before surgery. Class III evidence suggests a benefit to medical management over surgery in the treatment of patients with prolactinomas at primary diagnosis. There are insufficient data to support the benefit of endoscopic surgery compared with microscopic surgery, with or without additional adjuvant surgical techniques, for extent of surgical resection, hormone remission, length of stay, or complication rate, in the treatment of functional PA. There is a suggestion, however, that the endoscopic technique may be superior to the microscopic technique, for a shorter operative time and for extent of surgical resection and hormone remission rates for noninvasive pituitary macroadenomas. Similarly, there are insufficient data to support the use of reoperation for recurrent tumor compared with radiation and/or medical treatment.</p>\",\"PeriodicalId\":19276,\"journal\":{\"name\":\"Neurosurgery\",\"volume\":\"97 3S\",\"pages\":\"S24-S35\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-08-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurosurgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1227/neu.0000000000003559\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurosurgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1227/neu.0000000000003559","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for the Role of Surgery for Patients With Functioning Pituitary Adenomas.
Background and objectives: With the recent improvements in surgery, along with our ability to manage many pituitary tumors medically, the exact role of surgery for the treatment of functioning pituitary adenomas (PA) remains unclear. The purpose of this evidence-based clinical practice guideline was to determine the role of surgery in the treatment of functioning PA.
Methods: A systematic review of the literature was performed using the National Library of Medicine/PubMed database and Embase for studies relevant to the role of surgery in the treatment of patients with functioning PA. Clinical studies evaluating the role of trans-sphenoidal surgery vs medical management, endoscopic techniques vs microsurgery, the benefit of the use of adjunct surgical techniques to patient outcome, and the role of second surgery were selected for review.
Results: The literature search yielded 7073 abstracts. Of these, 60 studies met inclusion criteria, and evidence-based guidelines were formulated on the use of surgical resection compared with medical management, the use of endoscopic techniques and/or other surgical adjunct techniques, and the benefit of reoperation for recurrent tumors compared with medical treatment and/or radiation.
Conclusion: Class III evidence suggests a benefit to surgery over medical management for growth hormone-secreting adenomas without evidence to support a benefit to pretreatment with a somatostatin analog before surgery. Class III evidence suggests a benefit to medical management over surgery in the treatment of patients with prolactinomas at primary diagnosis. There are insufficient data to support the benefit of endoscopic surgery compared with microscopic surgery, with or without additional adjuvant surgical techniques, for extent of surgical resection, hormone remission, length of stay, or complication rate, in the treatment of functional PA. There is a suggestion, however, that the endoscopic technique may be superior to the microscopic technique, for a shorter operative time and for extent of surgical resection and hormone remission rates for noninvasive pituitary macroadenomas. Similarly, there are insufficient data to support the use of reoperation for recurrent tumor compared with radiation and/or medical treatment.
期刊介绍:
Neurosurgery, the official journal of the Congress of Neurological Surgeons, publishes research on clinical and experimental neurosurgery covering the very latest developments in science, technology, and medicine. For professionals aware of the rapid pace of developments in the field, this journal is nothing short of indispensable as the most complete window on the contemporary field of neurosurgery.
Neurosurgery is the fastest-growing journal in the field, with a worldwide reputation for reliable coverage delivered with a fresh and dynamic outlook.